Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molsidomine in Stable Angina Pectoris Undergoing PCI
NCT01363661Phase 4Completed
- Sponsor
- Therabel
- Start
- Jun 2011
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in stable angina pectoris and endothelial dysfunction comparing Molsidomine with Placebo (2 arms). Primary endpoint: Change Versus Baseline in the Score of the EndoPAT at 12 months. Started Jun 2011; status: completed.
02
Drugs
molsidomine
03
Conditions
stable angina pectorisendothelial dysfunction
Beyond the preview
Go deeper on NCT01363661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01363661.